カテゴリー： Market Monitor Global, 世界, 医療/バイオ

インターロイキン17Aの世界市場見通し2023年-2029年

◆英語タイトル：Interleukin 17A Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8518 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：70 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Interleukin 17A Market 調査レポートは次の情報を含め、グローバルにおけるのインターロイキン17A市場規模と予測を収録しています。・世界のインターロイキン17A市場：売上、2018年-2023年、2024年-2029年
・世界のインターロイキン17A市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のインターロイキン17A市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ABY-035」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

インターロイキン17Aのグローバル主要企業は、AbbVie Inc、 Abeome Corporation、 Affibody AB、 Cell Medica Limited、 Eli Lilly and Company、 Johnson & Johnson、 Merck KGaA、 Novartis AG、 Orega Biotech SASなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、インターロイキン17Aのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のインターロイキン17A市場：タイプ別、2018年-2023年、2024年-2029年
世界のインターロイキン17A市場：タイプ別市場シェア、2022年
・ABY-035、CNTO-6785、DLX-2882、他

世界のインターロイキン17A市場：用途別、2018年-2023年、2024年-2029年
世界のインターロイキン17A市場：用途別市場シェア、2022年
・慢性疼痛、肝臓がん、腎臓がん、その他

世界のインターロイキン17A市場：地域・国別、2018年-2023年、2024年-2029年
世界のインターロイキン17A市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるインターロイキン17Aのグローバル売上、2018年-2023年
・主要企業におけるインターロイキン17Aのグローバル売上シェア、2022年
・主要企業におけるインターロイキン17Aのグローバル販売量、2018年-2023年
・主要企業におけるインターロイキン17Aのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
AbbVie Inc、 Abeome Corporation、 Affibody AB、 Cell Medica Limited、 Eli Lilly and Company、 Johnson & Johnson、 Merck KGaA、 Novartis AG、 Orega Biotech SAS

*************************************************************

・調査・分析レポートの概要
インターロイキン17A市場の定義
市場セグメント
世界のインターロイキン17A市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のインターロイキン17A市場規模
世界のインターロイキン17A市場規模：2022年 VS 2029年
世界のインターロイキン17A市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのインターロイキン17Aの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のインターロイキン17A製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ABY-035、CNTO-6785、DLX-2882、他
インターロイキン17Aのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：慢性疼痛、肝臓がん、腎臓がん、その他
インターロイキン17Aの用途別グローバル売上・予測

・地域別市場分析
地域別インターロイキン17A市場規模 2022年と2029年
地域別インターロイキン17A売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
AbbVie Inc、 Abeome Corporation、 Affibody AB、 Cell Medica Limited、 Eli Lilly and Company、 Johnson & Johnson、 Merck KGaA、 Novartis AG、 Orega Biotech SAS
...

This report aims to provide a comprehensive presentation of the global market for Interleukin 17A, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interleukin 17A. This report contains market size and forecasts of Interleukin 17A in global, including the following market information:
Global Interleukin 17A Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Interleukin 17A Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Interleukin 17A companies in 2022 (%)
The global Interleukin 17A market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
ABY-035 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Interleukin 17A include AbbVie Inc, Abeome Corporation, Affibody AB, Cell Medica Limited, Eli Lilly and Company, Johnson & Johnson, Merck KGaA, Novartis AG and Orega Biotech SAS, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Interleukin 17A manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Interleukin 17A Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Interleukin 17A Market Segment Percentages, by Type, 2022 (%)
ABY-035
CNTO-6785
DLX-2882
Others
Global Interleukin 17A Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Interleukin 17A Market Segment Percentages, by Application, 2022 (%)
Chronic Pain
Liver Cancer
Kidney Cancer
Others
Global Interleukin 17A Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Interleukin 17A Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Interleukin 17A revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Interleukin 17A revenues share in global market, 2022 (%)
Key companies Interleukin 17A sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Interleukin 17A sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie Inc
Abeome Corporation
Affibody AB
Cell Medica Limited
Eli Lilly and Company
Johnson & Johnson
Merck KGaA
Novartis AG
Orega Biotech SAS
Outline of Major Chapters:
Chapter 1: Introduces the definition of Interleukin 17A, market overview.
Chapter 2: Global Interleukin 17A market size in revenue and volume.
Chapter 3: Detailed analysis of Interleukin 17A manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Interleukin 17A in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Interleukin 17A capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Interleukin 17A Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Interleukin 17A Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Interleukin 17A Overall Market Size
2.1 Global Interleukin 17A Market Size: 2022 VS 2029
2.2 Global Interleukin 17A Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Interleukin 17A Sales: 2018-2029
3 Company Landscape
3.1 Top Interleukin 17A Players in Global Market
3.2 Top Global Interleukin 17A Companies Ranked by Revenue
3.3 Global Interleukin 17A Revenue by Companies
3.4 Global Interleukin 17A Sales by Companies
3.5 Global Interleukin 17A Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Interleukin 17A Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Interleukin 17A Product Type
3.8 Tier 1, Tier 2 and Tier 3 Interleukin 17A Players in Global Market
3.8.1 List of Global Tier 1 Interleukin 17A Companies
3.8.2 List of Global Tier 2 and Tier 3 Interleukin 17A Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Interleukin 17A Market Size Markets, 2022 & 2029
4.1.2 ABY-035
4.1.3 CNTO-6785
4.1.4 DLX-2882
4.1.5 Others
4.2 By Type – Global Interleukin 17A Revenue & Forecasts
4.2.1 By Type – Global Interleukin 17A Revenue, 2018-2023
4.2.2 By Type – Global Interleukin 17A Revenue, 2024-2029
4.2.3 By Type – Global Interleukin 17A Revenue Market Share, 2018-2029
4.3 By Type – Global Interleukin 17A Sales & Forecasts
4.3.1 By Type – Global Interleukin 17A Sales, 2018-2023
4.3.2 By Type – Global Interleukin 17A Sales, 2024-2029
4.3.3 By Type – Global Interleukin 17A Sales Market Share, 2018-2029
4.4 By Type – Global Interleukin 17A Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Interleukin 17A Market Size, 2022 & 2029
5.1.2 Chronic Pain
5.1.3 Liver Cancer
5.1.4 Kidney Cancer
5.1.5 Others
5.2 By Application – Global Interleukin 17A Revenue & Forecasts
5.2.1 By Application – Global Interleukin 17A Revenue, 2018-2023
5.2.2 By Application – Global Interleukin 17A Revenue, 2024-2029
5.2.3 By Application – Global Interleukin 17A Revenue Market Share, 2018-2029
5.3 By Application – Global Interleukin 17A Sales & Forecasts
5.3.1 By Application – Global Interleukin 17A Sales, 2018-2023
5.3.2 By Application – Global Interleukin 17A Sales, 2024-2029
5.3.3 By Application – Global Interleukin 17A Sales Market Share, 2018-2029
5.4 By Application – Global Interleukin 17A Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Interleukin 17A Market Size, 2022 & 2029
6.2 By Region – Global Interleukin 17A Revenue & Forecasts
6.2.1 By Region – Global Interleukin 17A Revenue, 2018-2023
6.2.2 By Region – Global Interleukin 17A Revenue, 2024-2029
6.2.3 By Region – Global Interleukin 17A Revenue Market Share, 2018-2029
6.3 By Region – Global Interleukin 17A Sales & Forecasts
6.3.1 By Region – Global Interleukin 17A Sales, 2018-2023
6.3.2 By Region – Global Interleukin 17A Sales, 2024-2029
6.3.3 By Region – Global Interleukin 17A Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Interleukin 17A Revenue, 2018-2029
6.4.2 By Country – North America Interleukin 17A Sales, 2018-2029
6.4.3 US Interleukin 17A Market Size, 2018-2029
6.4.4 Canada Interleukin 17A Market Size, 2018-2029
6.4.5 Mexico Interleukin 17A Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Interleukin 17A Revenue, 2018-2029
6.5.2 By Country – Europe Interleukin 17A Sales, 2018-2029
6.5.3 Germany Interleukin 17A Market Size, 2018-2029
6.5.4 France Interleukin 17A Market Size, 2018-2029
6.5.5 U.K. Interleukin 17A Market Size, 2018-2029
6.5.6 Italy Interleukin 17A Market Size, 2018-2029
6.5.7 Russia Interleukin 17A Market Size, 2018-2029
6.5.8 Nordic Countries Interleukin 17A Market Size, 2018-2029
6.5.9 Benelux Interleukin 17A Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Interleukin 17A Revenue, 2018-2029
6.6.2 By Region – Asia Interleukin 17A Sales, 2018-2029
6.6.3 China Interleukin 17A Market Size, 2018-2029
6.6.4 Japan Interleukin 17A Market Size, 2018-2029
6.6.5 South Korea Interleukin 17A Market Size, 2018-2029
6.6.6 Southeast Asia Interleukin 17A Market Size, 2018-2029
6.6.7 India Interleukin 17A Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Interleukin 17A Revenue, 2018-2029
6.7.2 By Country – South America Interleukin 17A Sales, 2018-2029
6.7.3 Brazil Interleukin 17A Market Size, 2018-2029
6.7.4 Argentina Interleukin 17A Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Interleukin 17A Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Interleukin 17A Sales, 2018-2029
6.8.3 Turkey Interleukin 17A Market Size, 2018-2029
6.8.4 Israel Interleukin 17A Market Size, 2018-2029
6.8.5 Saudi Arabia Interleukin 17A Market Size, 2018-2029
6.8.6 UAE Interleukin 17A Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AbbVie Inc
7.1.1 AbbVie Inc Company Summary
7.1.2 AbbVie Inc Business Overview
7.1.3 AbbVie Inc Interleukin 17A Major Product Offerings
7.1.4 AbbVie Inc Interleukin 17A Sales and Revenue in Global (2018-2023)
7.1.5 AbbVie Inc Key News & Latest Developments
7.2 Abeome Corporation
7.2.1 Abeome Corporation Company Summary
7.2.2 Abeome Corporation Business Overview
7.2.3 Abeome Corporation Interleukin 17A Major Product Offerings
7.2.4 Abeome Corporation Interleukin 17A Sales and Revenue in Global (2018-2023)
7.2.5 Abeome Corporation Key News & Latest Developments
7.3 Affibody AB
7.3.1 Affibody AB Company Summary
7.3.2 Affibody AB Business Overview
7.3.3 Affibody AB Interleukin 17A Major Product Offerings
7.3.4 Affibody AB Interleukin 17A Sales and Revenue in Global (2018-2023)
7.3.5 Affibody AB Key News & Latest Developments
7.4 Cell Medica Limited
7.4.1 Cell Medica Limited Company Summary
7.4.2 Cell Medica Limited Business Overview
7.4.3 Cell Medica Limited Interleukin 17A Major Product Offerings
7.4.4 Cell Medica Limited Interleukin 17A Sales and Revenue in Global (2018-2023)
7.4.5 Cell Medica Limited Key News & Latest Developments
7.5 Eli Lilly and Company
7.5.1 Eli Lilly and Company Company Summary
7.5.2 Eli Lilly and Company Business Overview
7.5.3 Eli Lilly and Company Interleukin 17A Major Product Offerings
7.5.4 Eli Lilly and Company Interleukin 17A Sales and Revenue in Global (2018-2023)
7.5.5 Eli Lilly and Company Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Interleukin 17A Major Product Offerings
7.6.4 Johnson & Johnson Interleukin 17A Sales and Revenue in Global (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Merck KGaA
7.7.1 Merck KGaA Company Summary
7.7.2 Merck KGaA Business Overview
7.7.3 Merck KGaA Interleukin 17A Major Product Offerings
7.7.4 Merck KGaA Interleukin 17A Sales and Revenue in Global (2018-2023)
7.7.5 Merck KGaA Key News & Latest Developments
7.8 Novartis AG
7.8.1 Novartis AG Company Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Interleukin 17A Major Product Offerings
7.8.4 Novartis AG Interleukin 17A Sales and Revenue in Global (2018-2023)
7.8.5 Novartis AG Key News & Latest Developments
7.9 Orega Biotech SAS
7.9.1 Orega Biotech SAS Company Summary
7.9.2 Orega Biotech SAS Business Overview
7.9.3 Orega Biotech SAS Interleukin 17A Major Product Offerings
7.9.4 Orega Biotech SAS Interleukin 17A Sales and Revenue in Global (2018-2023)
7.9.5 Orega Biotech SAS Key News & Latest Developments
8 Global Interleukin 17A Production Capacity, Analysis
8.1 Global Interleukin 17A Production Capacity, 2018-2029
8.2 Interleukin 17A Production Capacity of Key Manufacturers in Global Market
8.3 Global Interleukin 17A Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Interleukin 17A Supply Chain Analysis
10.1 Interleukin 17A Industry Value Chain
10.2 Interleukin 17A Upstream Market
10.3 Interleukin 17A Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Interleukin 17A Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Interleukin 17A in Global Market
Table 2. Top Interleukin 17A Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Interleukin 17A Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Interleukin 17A Revenue Share by Companies, 2018-2023
Table 5. Global Interleukin 17A Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Interleukin 17A Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Interleukin 17A Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Interleukin 17A Product Type
Table 9. List of Global Tier 1 Interleukin 17A Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Interleukin 17A Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Interleukin 17A Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Interleukin 17A Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Interleukin 17A Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Interleukin 17A Sales (K Pcs), 2018-2023
Table 15. By Type - Global Interleukin 17A Sales (K Pcs), 2024-2029
Table 16. By Application – Global Interleukin 17A Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Interleukin 17A Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Interleukin 17A Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Interleukin 17A Sales (K Pcs), 2018-2023
Table 20. By Application - Global Interleukin 17A Sales (K Pcs), 2024-2029
Table 21. By Region – Global Interleukin 17A Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Interleukin 17A Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Interleukin 17A Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Interleukin 17A Sales (K Pcs), 2018-2023
Table 25. By Region - Global Interleukin 17A Sales (K Pcs), 2024-2029
Table 26. By Country - North America Interleukin 17A Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Interleukin 17A Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Interleukin 17A Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Interleukin 17A Sales, (K Pcs), 2024-2029
Table 30. By Country - Europe Interleukin 17A Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Interleukin 17A Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Interleukin 17A Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Interleukin 17A Sales, (K Pcs), 2024-2029
Table 34. By Region - Asia Interleukin 17A Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Interleukin 17A Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Interleukin 17A Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Interleukin 17A Sales, (K Pcs), 2024-2029
Table 38. By Country - South America Interleukin 17A Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Interleukin 17A Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Interleukin 17A Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Interleukin 17A Sales, (K Pcs), 2024-2029
Table 42. By Country - Middle East & Africa Interleukin 17A Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Interleukin 17A Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Interleukin 17A Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Interleukin 17A Sales, (K Pcs), 2024-2029
Table 46. AbbVie Inc Company Summary
Table 47. AbbVie Inc Interleukin 17A Product Offerings
Table 48. AbbVie Inc Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. AbbVie Inc Key News & Latest Developments
Table 50. Abeome Corporation Company Summary
Table 51. Abeome Corporation Interleukin 17A Product Offerings
Table 52. Abeome Corporation Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Abeome Corporation Key News & Latest Developments
Table 54. Affibody AB Company Summary
Table 55. Affibody AB Interleukin 17A Product Offerings
Table 56. Affibody AB Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Affibody AB Key News & Latest Developments
Table 58. Cell Medica Limited Company Summary
Table 59. Cell Medica Limited Interleukin 17A Product Offerings
Table 60. Cell Medica Limited Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Cell Medica Limited Key News & Latest Developments
Table 62. Eli Lilly and Company Company Summary
Table 63. Eli Lilly and Company Interleukin 17A Product Offerings
Table 64. Eli Lilly and Company Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Eli Lilly and Company Key News & Latest Developments
Table 66. Johnson & Johnson Company Summary
Table 67. Johnson & Johnson Interleukin 17A Product Offerings
Table 68. Johnson & Johnson Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Johnson & Johnson Key News & Latest Developments
Table 70. Merck KGaA Company Summary
Table 71. Merck KGaA Interleukin 17A Product Offerings
Table 72. Merck KGaA Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Merck KGaA Key News & Latest Developments
Table 74. Novartis AG Company Summary
Table 75. Novartis AG Interleukin 17A Product Offerings
Table 76. Novartis AG Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Novartis AG Key News & Latest Developments
Table 78. Orega Biotech SAS Company Summary
Table 79. Orega Biotech SAS Interleukin 17A Product Offerings
Table 80. Orega Biotech SAS Interleukin 17A Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. Orega Biotech SAS Key News & Latest Developments
Table 82. Interleukin 17A Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 83. Global Interleukin 17A Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Interleukin 17A Production by Region, 2018-2023 (K Pcs)
Table 85. Global Interleukin 17A Production by Region, 2024-2029 (K Pcs)
Table 86. Interleukin 17A Market Opportunities & Trends in Global Market
Table 87. Interleukin 17A Market Drivers in Global Market
Table 88. Interleukin 17A Market Restraints in Global Market
Table 89. Interleukin 17A Raw Materials
Table 90. Interleukin 17A Raw Materials Suppliers in Global Market
Table 91. Typical Interleukin 17A Downstream
Table 92. Interleukin 17A Downstream Clients in Global Market
Table 93. Interleukin 17A Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Interleukin 17A Segment by Type in 2022
Figure 2. Interleukin 17A Segment by Application in 2022
Figure 3. Global Interleukin 17A Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Interleukin 17A Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Interleukin 17A Revenue, 2018-2029 (US$, Mn)
Figure 7. Interleukin 17A Sales in Global Market: 2018-2029 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Interleukin 17A Revenue in 2022
Figure 9. By Type - Global Interleukin 17A Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Interleukin 17A Revenue Market Share, 2018-2029
Figure 11. By Type - Global Interleukin 17A Sales Market Share, 2018-2029
Figure 12. By Type - Global Interleukin 17A Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global Interleukin 17A Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Interleukin 17A Revenue Market Share, 2018-2029
Figure 15. By Application - Global Interleukin 17A Sales Market Share, 2018-2029
Figure 16. By Application - Global Interleukin 17A Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global Interleukin 17A Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Interleukin 17A Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Interleukin 17A Revenue Market Share, 2018-2029
Figure 20. By Region - Global Interleukin 17A Sales Market Share, 2018-2029
Figure 21. By Country - North America Interleukin 17A Revenue Market Share, 2018-2029
Figure 22. By Country - North America Interleukin 17A Sales Market Share, 2018-2029
Figure 23. US Interleukin 17A Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Interleukin 17A Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Interleukin 17A Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Interleukin 17A Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Interleukin 17A Sales Market Share, 2018-2029
Figure 28. Germany Interleukin 17A Revenue, (US$, Mn), 2018-2029
Figure 29. France Interleukin 17A Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Interleukin 17A Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Interleukin 17A Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Interleukin 17A Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Interleukin 17A Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Interleukin 17A Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Interleukin 17A Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Interleukin 17A Sales Market Share, 2018-2029
Figure 37. China Interleukin 17A Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Interleukin 17A Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Interleukin 17A Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Interleukin 17A Revenue, (US$, Mn), 2018-2029
Figure 41. India Interleukin 17A Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Interleukin 17A Revenue Market Share, 2018-2029
Figure 43. By Country - South America Interleukin 17A Sales Market Share, 2018-2029
Figure 44. Brazil Interleukin 17A Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Interleukin 17A Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Interleukin 17A Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Interleukin 17A Sales Market Share, 2018-2029
Figure 48. Turkey Interleukin 17A Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Interleukin 17A Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Interleukin 17A Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Interleukin 17A Revenue, (US$, Mn), 2018-2029
Figure 52. Global Interleukin 17A Production Capacity (K Pcs), 2018-2029
Figure 53. The Percentage of Production Interleukin 17A by Region, 2022 VS 2029
Figure 54. Interleukin 17A Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ インターロイキン17Aの世界市場見通し2023年-2029年(Interleukin 17A Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

インターロイキン17Aの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp